Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07190807 · ClinicalTrials.gov registry record · NA
Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control
A NA study of Chronic Pain and Low Back Pain, sponsored by Boston Scientific Corporation.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 7
- Study locations
NCT07190807: Recruiting NA study of Chronic Pain and Low Back Pain, sponsored by Boston Scientific Corporation.
NCT07190807 is a NA study of Chronic Pain and Low Back Pain that is actively recruiting participants, run by Boston Scientific Corporation. The registered enrollment target is 70 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (91% lower). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07190807, a NA study of Chronic Pain and Low Back Pain, is actively recruiting participants, sponsored by Boston Scientific Corporation.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 7
- Study locations
Study Summary
Study to evaluate the effectiveness of time variant pulse (TVP)-SCS in patients with chronic pain using commercially approved Boston Scientific SCS Systems per local Instructions for use (IFU). In addition, to compile real-world clinical outcomes in subjects with chronic, intractable low back and/or leg pain.
Primary Outcome
Proportion of subjects with 50% or greater reduction from Baseline Visit in average targeted pain intensity at 3 months post-activation
Conditions Studied
Interventions
- DEVICE Boston Scientific WaveWriter Alpha™ SCS Systems
Study Locations (7)
Colorado
- Denver Back Pain Specialists - Greenwood
Florida
- Orlando Health Neuroscience Institute - Clermont
Louisiana
- Ochsner Clinic Foundation - New Orleans
New York
- Montefiore Medical Center - The Bronx
Pennsylvania
- Fox Chase Pain Management - Trevose
South Carolina
- PCPMG Clinical Research Unit, LLC - Greenville
Texas
- Institute of Precision Pain Medicine - Corpus Christi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2025-11-07 |
| Est. Completion | 2029-05 |
| Phase | NA |
What NCT07190807 shows while recruiting
NCT07190807 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (91% lower).
The record links to 6 conditions, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Boston Scientific WaveWriter Alpha™ SCS Systems is the first listed.
NCT07190807 lists 7 locations in 7 states (Colorado, Florida, Louisiana).
Frequently Asked Questions
What is clinical trial NCT07190807 about?
NCT07190807 is a clinical study titled "Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control". Study to evaluate the effectiveness of time variant pulse (TVP)-SCS in patients with chronic pain using commercially approved Boston Scientific SCS Systems per local Instructions for use (IFU). In addition, to compile real-world clinical outcomes in subjects with chronic, intractable low back and/o...
What is the current status of trial NCT07190807?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2025-11-07. Estimated completion is 2029-05.
What conditions does trial NCT07190807 study?
This clinical trial studies the following conditions: Chronic Pain, Low Back Pain, Chronic Low Back Pain, Intractable Pain, Leg Pain.
What interventions are being tested in trial NCT07190807?
The interventions under investigation include: Boston Scientific WaveWriter Alpha™ SCS Systems (DEVICE).
Who is sponsoring clinical trial NCT07190807?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07190807 being conducted?
This trial has 7 study locations across Colorado, Florida, Louisiana, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07190807's enrollment target sits among peer trials
70 167th of 301 higher than 134 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI